EXAS vs FRPH · rev $2.76B vs P/E 74, rev $21.7M
EXACT Sciences Corporation (EXAS) versus Frp Holdings Ord (FRPH) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Frp Holdings Ord (FRPH) is a real estate services company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported FRPH revenue for 2026-06-30 was $21.7M. Net income was -$946.0K. FRPH currently screens at market cap $509.4M and trailing P/E 74.1.
EXAS currently screens at market cap $20.03B. FRPH currently screens at market cap $509.4M and trailing P/E 74.1.
Not investment advice. Open the EXAS and FRPH stock pages for the full models.
Not investment advice.